UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Risk management of project information system operation and maintenance based on Cloud Computing

International journal of system assurance engineering and management, 2023-02, Vol.14 (1), p.176-187

Mao, Qunying

2023

Volltextzugriff (PDF)

Impact of the Delta variant on vaccine efficacy and response strategies

Expert review of vaccines, 2021-10, Vol.20 (10), p.1201-1209

2021

Volltextzugriff (PDF)

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

The New England journal of medicine, 2014-02, Vol.370 (9), p.818-828

2014

Volltextzugriff (PDF)

An Inactivated Enterovirus 71 Vaccine in Healthy Children

The New England journal of medicine, 2014-02, Vol.370 (9), p.829-837

2014

Volltextzugriff (PDF)

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations

Frontiers in immunology, 2021-04, Vol.12, p.669339-669339

2021

Volltextzugriff (PDF)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Emerging microbes & infections, 2021, Vol.10 (1), p.629-637

2021

Volltextzugriff (PDF)

Research progress on circular RNA vaccines

Frontiers in immunology, 2023-01, Vol.13, p.1091797-1091797

2023

Volltextzugriff (PDF)

A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation

Journal of Virology, 2012-11, Vol.86 (22), p.11967-11976

2012

Volltextzugriff (PDF)

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays

Expert review of vaccines, 2023-12, Vol.22 (1), p.270-277

2023

Volltextzugriff (PDF)

Research Advances on the Stability of mRNA Vaccines

Viruses, 2023-03, Vol.15 (3), p.668

2023

Volltextzugriff (PDF)

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases

Emerging microbes & infections, 2016, Vol.5 (7), p.e75-7

2016

Volltextzugriff (PDF)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy

Frontiers in immunology, 2023-10, Vol.14, p.1261243-1261243

2023

Volltextzugriff (PDF)

Research progress on the quality control of mRNA vaccines

Expert review of vaccines, 2024-12, Vol.23 (1), p.570-583

2024

Volltextzugriff (PDF)

A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model

Viruses, 2024-03, Vol.16 (3), p.484

2024

Volltextzugriff (PDF)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1598-1608

2021

Volltextzugriff (PDF)

Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Emerging microbes & infections, 2023-12, Vol.12 (1), p.2152388-2152388

2023

Volltextzugriff (PDF)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2164140-2164140

2023

Volltextzugriff (PDF)

COVID-19 vaccines: progress and understanding on quality control and evaluation

Signal transduction and targeted therapy, 2021-05, Vol.6 (1), p.199-199, Article 199

2021

Volltextzugriff (PDF)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (5), p.1-2057161

2022

Volltextzugriff (PDF)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines

Frontiers in immunology, 2022-04, Vol.13, p.814365-814365

2022

Volltextzugriff (PDF)

Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines

Expert review of vaccines, 2024, Vol.23 (1), p.362-370

2024

Volltextzugriff (PDF)

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates

Signal transduction and targeted therapy, 2022-03, Vol.7 (1), p.69-11, Article 69

2022

Volltextzugriff (PDF)

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children

PloS one, 2013-11, Vol.8 (11), p.e79599-e79599

2013

Volltextzugriff (PDF)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice

Virology journal, 2022-05, Vol.19 (1), p.86-86, Article 86

2022

Volltextzugriff (PDF)

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Emerging microbes & infections, 2022-12, Vol.11 (1), p.1145-1153

2022

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(140)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(112)
Humans
(71)
Immunology
(48)
Animals
(33)
Female
(33)
Vaccines
(32)
Male
(27)
Biotechnology & Applied Microbiology
(23)
Enterovirus A, Human - Immunology
(22)
Infectious Diseases
(22)
Vaccine
(22)
Microbiology
(21)
Mice
(20)
Immunogenicity
(19)
Viral Vaccines - Immunology
(19)
Virology
(19)
Covid-19 Vaccines
(18)
Antibodies, Neutralizing - Blood
(17)
Antibodies, Viral - Blood
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Risk management of project information system operation and maintenance based on Cloud Computing

Impact of the Delta variant on vaccine efficacy and response strategies

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

An Inactivated Enterovirus 71 Vaccine in Healthy Children

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Research progress on circular RNA vaccines

A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays

Research Advances on the Stability of mRNA Vaccines

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy

Research progress on the quality control of mRNA vaccines

A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody

COVID-19 vaccines: progress and understanding on quality control and evaluation

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines

Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Suchergebnisse filtern